Phase 2 Trial of SBRT and Gene Therapy Prior to Nivolumab for NSCLC – Cancer Therapy Advisor
Cancer Therapy Advisor |
Phase 2 Trial of SBRT and Gene Therapy Prior to Nivolumab for NSCLC
Cancer Therapy Advisor Researchers are evaluating whether patients with metastatic NSCLC will benefit from stereotactic body radiation and a virally mediated gene therapy prior to nivolumab. Title: ENSIGN: Phase II Window of Opportunity Trial of Stereotactic Body Radiation … |
